HomeCompareEQMEF vs JNJ

EQMEF vs JNJ: Dividend Comparison 2026

EQMEF yields 900.90% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQMEF wins by $7634567.46M in total portfolio value
10 years
EQMEF
EQMEF
● Live price
900.90%
Share price
$0.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7634567.49M
Annual income
$6,266,297,597,749.10
Full EQMEF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — EQMEF vs JNJ

📍 EQMEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEQMEFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EQMEF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EQMEF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EQMEF
Annual income on $10K today (after 15% tax)
$76,576.58/yr
After 10yr DRIP, annual income (after tax)
$5,326,352,958,086.73/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, EQMEF beats the other by $5,326,352,954,049.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EQMEF + JNJ for your $10,000?

EQMEF: 50%JNJ: 50%
100% JNJ50/50100% EQMEF
Portfolio after 10yr
$3817283.76M
Annual income
$3,133,148,801,249.49/yr
Blended yield
82.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EQMEF
No analyst data
Altman Z
44.9
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EQMEF buys
0
JNJ buys
0
No recent congressional trades found for EQMEF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEQMEFJNJ
Forward yield900.90%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$7634567.49M$30.5K
Annual income after 10y$6,266,297,597,749.10$4,749.88
Total dividends collected$7528407.85M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EQMEF vs JNJ ($10,000, DRIP)

YearEQMEF PortfolioEQMEF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$100,790$90,090.09$10,594$274.49+$90.2KEQMEF
2$956,461$848,615.73$11,294$360.69+$945.2KEQMEF
3$8,549,631$7,526,217.92$12,133$476.91+$8.54MEQMEF
4$72,022,393$62,874,287.34$13,156$635.42+$72.01MEQMEF
5$572,068,813$495,004,852.85$14,432$854.61+$572.05MEQMEF
6$4,286,682,617$3,674,568,986.74$16,056$1,162.76+$4286.67MEQMEF
7$30,320,062,361$25,733,311,961.41$18,175$1,604.53+$30320.04MEQMEF
8$202,548,872,218$170,106,405,491.19$21,009$2,252.68+$202548.85MEQMEF
9$1,278,756,912,645$1,062,029,619,371.43$24,911$3,229.73+$1278756.89MEQMEF
10$7,634,567,494,279$6,266,297,597,749.10$30,458$4,749.88+$7634567.46MEQMEF

EQMEF vs JNJ: Complete Analysis 2026

EQMEFStock

Equity Metals Corporation engages in the acquisition, exploration, and development of mineral properties in Canada. The company explores for gold, silver, zinc, copper, and diamond ores. It owns a 100% interest in the Silver Queen property consists of 17 crown-granted and 45 tenure claims covering an area of 18, 851.76 hectares located in the Omineca Mining Division, near Owen Lake, British Columbia; 57.49% interest in the Monument Diamond property located on the south shore of Lac de Gras in the Northwest Territories; and 100% in Saskatchewan Silica Sand lease covering an area of 54 acres. The company was formerly known as New Nadina Explorations Limited and changed its name to Equity Metals Corporation in September 2019. Equity Metals Corporation was incorporated in 1964 and is headquartered in Vancouver, Canada.

Full EQMEF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this EQMEF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EQMEF vs SCHDEQMEF vs JEPIEQMEF vs OEQMEF vs KOEQMEF vs MAINEQMEF vs ABBVEQMEF vs MRKEQMEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.